Sunshine Biopharma, Inc. (SBFM)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.97
-1.23%
Mkt Cap $5.45M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 4, 2026 | $9.20M | — | — | -$0.16 | -$0.46 | -187.50% | — | — |
| Q2 2026 Apr 3, 2026 | $10.00M | $8.58M | -14.23% | -$0.27 | -$0.30 | -11.11% | — | — |
| Q4 2025 Nov 13, 2025 | $11.10M | $9.42M | -15.16% | -$0.13 | -$0.19 | -46.15% | — | — |
| Q3 2025 Aug 12, 2025 | $11.10M | $9.41M | -15.22% | -$0.11 | -$0.39 | -254.55% | — | — |
| Q2 2025 May 15, 2025 | — | $8.90M | — | — | -$0.44 | — | — | — |
| Q4 2024 Nov 5, 2024 | $12.50M | $8.44M | -32.52% | $9.00 | -$0.94 | -110.44% | — | — |
| Q3 2024 Aug 16, 2024 | $9.30M | $9.30M | +0.00% | -$7.40 | -$9.94 | -34.32% | — | — |
| Q2 2024 May 20, 2024 | $7.00M | $7.54M | +7.73% | -$1.04 | -$40.00 | -3746.15% | — | — |
| Q1 2024 Mar 28, 2024 | $6.10M | $7.68M | +25.90% | -$3.00 | -$100.00 | -3233.33% | — | — |
| Q4 2023 Nov 13, 2023 | $6.10M | $5.96M | -2.33% | -$0.06 | -$80.00 | -133233.33% | — | — |
| Q3 2023 Aug 11, 2023 | $5.00M | $5.56M | +11.22% | -$160.00 | -$40.00 | +75.00% | — | — |
| Q2 2023 May 10, 2023 | — | $4.89M | — | — | -$160.00 | — | — | — |
| Q2 2023 Apr 4, 2023 | — | $3.94M | — | — | -$3000.00 | — | — | — |
| Q4 2022 Nov 7, 2022 | — | $132.81K | — | — | -$160.00 | — | — | — |
| Q3 2022 Aug 3, 2022 | — | $150.31K | — | — | -$60.00 | — | — | — |
| Q2 2022 May 6, 2022 | — | $122.64K | — | — | -$0.23 | — | — | — |
| Q1 2022 Mar 21, 2022 | — | $85.12K | — | — | $0.19 | — | — | — |
| Q4 2021 Nov 9, 2021 | — | $50.38K | — | — | -$1.59 | — | — | — |
| Q3 2021 Aug 9, 2021 | — | $52.87K | — | — | -$1.20 | — | — | — |
| Q2 2021 May 11, 2021 | — | $40.06K | — | — | -$2.82 | — | — | — |